Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced Hepatocellular Carcinoma.
Cancer Res Treat
; 51(2): 510-518, 2019 Apr.
Article
in En
| MEDLINE
| ID: mdl-29898591
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Hepatocellular
/
STAT3 Transcription Factor
/
Liver Neoplasms
/
Antineoplastic Agents
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Cancer Res Treat
Year:
2019
Document type:
Article
Country of publication: